Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATRS | MCK | BDX | CAH | WST |
| Company | Antares Pharma | Mckesson Corp | Becton Dickinson and Company | Cardinal Health | West Pharmaceutical Services |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 5.58 | 810.97 | 195.10 | 198.83 | 269.30 |
| High | 5.60 | 819.39 | 196.98 | 200.90 | 271.41 |
| Low | 5.58 | 807.75 | 194.27 | 197.56 | 266.80 |
| Latest | 5.59 | 811.72 | 194.92 | 198.95 | 267.13 |
| Change | unch | +5.20 | -0.44 | +0.51 | -2.00 |
| % Change | unch | +0.64% | -0.23% | +0.26% | -0.74% |
| Volume | 2,707,400 | 435,416 | 746,291 | 854,175 | 339,600 |
| 20-Day Average Volume | 3,885,230 | 815,556 | 1,973,539 | 2,323,216 | 682,179 |
| Previous Close | 5.59 | 806.52 | 195.36 | 198.44 | 269.13 |
| Industry | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.57 | 832.07 | 194.26 | 203.26 | 272.44 |
| 20-Day Raw Stochastic | 83.33% | 20.79% | 48.11% | 16.45% | 44.32% |
| 20-Day Relative Strength | 76.57 | 48.14 | 54.10 | 57.39 | 47.88 |
| Weighted Alpha | +30.00 | +37.74 | -9.85 | +69.59 | -0.18 |
| Today's Opinion | 100% Buy | 56% Buy | 56% Buy | 80% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 56% Buy | 80% Buy | 40% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 8% Buy | 100% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.36% since 05/16/22 | -0.44% since 12/11/25 | -2.65% since 12/11/25 | +0.21% since 12/11/25 | -1.81% since 12/11/25 |
| Low | 5.57 on 05/18/22 | 801.21 on 12/17/25 | 194.33 on 12/18/25 | 195.54 on 12/16/25 | 264.92 on 12/17/25 |
| High | 5.60 on 05/23/22 | 826.00 on 12/12/25 | 202.75 on 12/12/25 | 200.85 on 12/18/25 | 275.56 on 12/17/25 |
| 1-Month | |||||
| %Chg | +0.36% since 04/22/22 | -5.67% since 11/18/25 | +1.45% since 11/18/25 | -3.98% since 11/18/25 | +2.87% since 11/18/25 |
| Low | 5.54 on 05/12/22 | 789.96 on 12/08/25 | 188.04 on 11/20/25 | 195.54 on 12/16/25 | 253.32 on 11/20/25 |
| High | 5.60 on 05/23/22 | 895.58 on 11/26/25 | 202.75 on 12/12/25 | 214.93 on 11/26/25 | 285.54 on 12/04/25 |
| 3-Month | |||||
| %Chg | +65.88% since 02/23/22 | +17.65% since 09/18/25 | +3.58% since 09/18/25 | +32.45% since 09/18/25 | +4.95% since 09/18/25 |
| Low | 3.24 on 02/24/22 | 687.68 on 09/22/25 | 162.29 on 11/06/25 | 145.87 on 09/25/25 | 249.76 on 09/24/25 |
| High | 5.60 on 05/23/22 | 895.58 on 11/26/25 | 202.75 on 12/12/25 | 214.93 on 11/26/25 | 322.34 on 10/23/25 |
| 6-Month | |||||
| %Chg | +63.93% since 11/23/21 | +11.39% since 06/18/25 | +15.74% since 06/18/25 | +20.15% since 06/18/25 | +22.78% since 06/18/25 |
| Low | 3.11 on 01/28/22 | 637.00 on 08/12/25 | 162.29 on 11/06/25 | 137.75 on 08/12/25 | 206.80 on 07/18/25 |
| High | 5.60 on 05/23/22 | 895.58 on 11/26/25 | 202.75 on 12/12/25 | 214.93 on 11/26/25 | 322.34 on 10/23/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 955,063 | 99,546,352 | 55,759,456 | 47,148,356 | 19,362,020 |
| Shares Outstanding, K | 170,852 | 123,427 | 285,419 | 237,595 | 71,943 |
| Annual Sales | 183,980,000 | 359,051,000,000 | 21,840,000,000 | 222,578,000,000 | 2,893,200,000 |
| Annual Net Income | 46,290,000 | 3,295,000,000 | 1,678,000,000 | 1,561,000,000 | 492,700,000 |
| Last Quarter Sales | 41,560,000 | 103,150,000,000 | 5,891,000,000 | 64,009,000,000 | 804,600,000 |
| Last Quarter Net Income | -2,320,000 | 1,110,000,000 | 493,000,000 | 450,000,000 | 140,000,000 |
| 60-Month Beta | 1.15 | 0.38 | 0.25 | 0.63 | 1.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 05/10/22 | 9.86 on 11/05/25 | 3.96 on 11/06/25 | 2.55 on 10/30/25 | 1.96 on 10/23/25 |
| Latest Earnings Date | 08/04/22 | 02/04/26 | 02/04/26 | 01/29/26 | 02/12/26 |
| Most Recent Dividend | N/A | 0.820 on 12/01/25 | 1.050 on 12/08/25 | 0.511 on 10/01/25 | 0.220 on 11/12/25 |
| Next Ex-Dividends Date | N/A | 12/01/25 | 12/08/25 | 01/02/26 | 01/28/26 |
| Ratios | |||||
| Price/Earnings ttm | 79.86 | 22.33 | 13.62 | 22.21 | 37.69 |